Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

lobal cholesterol joint venture net sales, which include VYTORIN and ZETIA, totaled $1.4 billion in the 2007 fourth quarter. Schering-Plough does not record sales of its cholesterol joint venture with Merck as the venture is accounted for under the equity method. Including an adjustment of an assumed 50 percent of the global cholesterol joint venture net sales, Schering- Plough's adjusted sales for the 2007 fourth quarter would have been $4.4 billion.

Overall, Schering-Plough shares in approximately 50 percent of the profits of the joint venture with Merck, although there are different profit-sharing arrangements for the cholesterol products in countries around the world. Schering-Plough records its share of the income from operations in "Equity income," which totaled $566 million in the 2007 fourth quarter, an increase of 40 percent versus $403 million in the fourth quarter of 2006. Schering-Plough noted that it incurs substantial costs such as selling, general and administrative costs that are not reflected in "Equity income" and are borne by its overall cost structure.

There is a separate co-marketing agreement with Bayer for ZETIA in Japan, where the product was launched in June 2007.

Sales of Global Pharmaceuticals for the 2007 fourth quarter totaled $3.0 billion. Included in the fourth quarter of 2007 are $409 million of net sales related to Organon, the OBS human health business.

Sales of REMICADE increased 35 percent to $455 million in the fourth quarter of 2007 due to continued market growth and expanded use across indications. REMICADE is a treatment for inflammatory diseases that Schering- Plough markets in countries outside the United States (except in Japan and certain other Asian markets) for rheumatoid arthritis, early rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, pediatric Crohn's disease and ulcerative colitis.

Global sales of NASONEX, an inhaled nasal cortico
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... DENVER and NEW ORLEANS , Feb. ... Board: CONX), a worldwide developer and marketer of diagnostic ... a major extension of the collaborative effort to combat ... an additional $800,000 in contract revenue for ... The National Institutes of Health (NIH) has awarded a ...
(Date:2/8/2010)... 8 Neurocrine Biosciences, Inc. (Nasdaq: ... H. Rastetter Ph.D. to its Board of Directors effective ... Officer of Receptos, Inc., and former Executive Chairman of ... welcome Bill Rastetter to our Board of ... of the Board of Neurocrine Biosciences.  "The company is ...
(Date:2/5/2010)... cheap, accurate test to find undetected landmines. , Students ... bacteria that glows green when it comes into contact ... can be mixed into a colourless solution that, when ... indicate the presence of landmines. , Researchers say ... be delivered from the air onto areas thought to ...
(Date:2/5/2010)... , Feb. 5 InfoSpi ... important development within the process of the negotiations ... Integral Bioenergies Systems, SL (IBS). This firm has ... allows the treatment of biomass/sludge obtained at sewage ... contract with Tedagua ( www.tedagua.com ), a member ...
Breaking Biology Technology:Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2InfoSpi Shall Benefit From Contract for Future Use of IBS Technology 2
... Tosoh Bioscience LLC and Richard Cornell, Wyeth BioPharma , , ... During a recent method optimization and investigation at Wyeth ... improved reproducibility and recovery , during the ... orthogonal purification of a 140 kDa apparent molecular weight protein , ...
... , , ... phases have been responsible for the growth of , ... recent years that such column types are not suited for reliable analysis ... aqueous mobile phase conditions. , It was shown that ...
... , Dr. ... Prof. Dr. Thomas Lisowsky, multiBIND biotec GmbH , ... , , ... sufficient to cause infections, recombinations or,biological transformations [1,2]. Additionally, the,complete decontamination of equipment ...
Other Biology Technology:Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns 2Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns 3Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns 4Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns 2New Insights Into DNA Decontamination 2New Insights Into DNA Decontamination 3New Insights Into DNA Decontamination 4New Insights Into DNA Decontamination 5
(Date:2/7/2010)... (TCE), a chemical once widely used to clean metal ... higher risk of developing Parkinson,s disease, according to a ... American Academy of Neurology,s 62nd Annual Meeting in Toronto ... the first time a population-based study has confirmed case ... risk of developing Parkinson,s disease," said study author Samuel ...
(Date:2/7/2010)... circles of DNA are the key to a new ... fat into induced pluripotent stem cells for use in ... of Medicine. Unlike other commonly used techniques, the method, ... not use viruses to introduce genes into the cells ... the first example of reprogramming adult cells to pluripotency ...
(Date:2/5/2010)... FAIRFAX, Va. , Feb. 5 /PRNewswire/ ... biometric identification technology, products and services, was once ... Supplemental Report as the most accurate iris technology ... OPS dataset, the next best competitor exhibits error ... with a commanding lead, IriTech continues to rapidly ...
Breaking Biology News(10 mins):Virus-free technique enables Stanford scientists to easily make stem cells pluripotent 2Virus-free technique enables Stanford scientists to easily make stem cells pluripotent 3Virus-free technique enables Stanford scientists to easily make stem cells pluripotent 4NIST Supplemental Testing Re-confirms IriTech is #1 Iris Identification Provider 2Learning Takes Place When You Get Things Right 53240 1Learning Takes Place When You Get Things Right 53240 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 1Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 3Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 4
... New biomolecular technologies have largely failed to deliver the ... bacteria, says a leading Canadian specialist in antibiotic resistance. ... screening were expected to make the development of new ... cases the microbes continue to hold the upper hand ...
... will be brought to the marketplace, giving laboratories ... Technology Transfer GmbH (EMBLEM), the commercial entity of ... that it has signed a licensing deal with ... technology called SPIM (Selective Plane Illumination Microscopy). , ...
... contains a report of some intriguing findings in cloned offspring ... to enucleated eggs of another genus of fish. , The ... cytoplasm of goldfish, were virtually identical to the nuclear donor ... The number of vertebrae in the clones, however, was in ...
Other Biology News:Learning to fight an adversary that won't stay down 2The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life 2
RECK (F-20)...
... Rabbit polyclonal to Peroxiredoxin 1 ... peroxidase family, whose mammalian members have ... proliferation, differentiation, and apoptosis. Many isoforms ... to the amino acid sequence homology, ...
... Synucleins are small, soluble proteins expressed ... tumors. The family includes three known proteins: ... The alpha and beta synuclein proteins are ... are seen mainly in presynaptic terminals. ...
This adapter allows the Thermo-Fast® 96 Semi-Skirted (AB-0900 and AB-0990) PCR plates to be used directly in the ABI PRISM® 3100 sequencer without the need for software changes....
Biology Products: